We are live on ! Find out more
NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $121M
1-Year Est. Return 56.89%
This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+56.89%
3 Year Est. Return
+244.35%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$123M
AUM Growth
+$5.7M
Cap. Flow
+$11.5M
Cap. Flow %
9.4%
Top 10 Hldgs %
64.1%
Holding
36
New
1
Increased
9
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
PTGX icon
Protagonist Therapeutics
PTGX
+$5.09M
2
XENE icon
Xenon Pharmaceuticals
XENE
+$1.97M
3
OCS icon
Oculis Holding
OCS
+$1.61M
4
ARGX icon
argenx
ARGX
+$1.5M
5
REPL icon
Replimune Group
REPL
+$1.14M

Top Sells

Rank Stock Value
1
RBRK icon
Rubrik
RBRK
+$1.59M
2
ONC
BeOne Medicines Ltd
ONC
+$999K
3
INCY icon
Incyte
INCY
+$558K

Sector Composition

Rank Sector Weight
1 Healthcare 99.8%
2 Materials 0.2%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
26
Revolution Medicines
RVMD
$44B
$681K 0.56%
19,253
– –
RANI icon
27
Rani Therapeutics
RANI
$89M
$622K 0.51%
493,584
– –
BCYC
28
Bicycle Therapeutics
BCYC
$292M
$585K 0.48%
68,943
– –
CLYM
29
Climb Bio
CLYM
$804M
$566K 0.46%
463,654
– –
BOLT icon
30
Bolt Biotherapeutics
BOLT
$7.78M
$467K 0.38%
58,348
– –
TRDA icon
31
Entrada Therapeutics
TRDA
$267M
$444K 0.36%
49,082
– –
DBVT
32
DBV Technologies
DBVT
$847M
$253K 0.21%
37,095
– –
BSLK
33
DELISTED
Bolt Projects Holdings
BSLK
$250K 0.2%
40,598
– –
AFMD
34
DELISTED
Affimed
AFMD
$26.9K 0.02%
37,247
– –
ALXO icon
35
ALX Oncology
ALXO
$290M
$26.1K 0.02%
41,950
– –
RBRK icon
36
Rubrik
RBRK
$18.5B
– –
-24,338
Closed -$1.59M
1
2

Similar funds

MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
CCM
Candelo Capital Management New York $121M AUM 113.39% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
MW
Merited Wealth North Bay Village, Florida $121M AUM

Nan Fung Group Holdings's Q1 2025 Portfolio in Review

As of Q1 2025, Nan Fung Group Holdings held 36 positions worth $123M, up 4.9% from $117M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Nan Fung Group Holdings deployed $11.5M of net new capital in Q1 2025, opening 1 new position and adding to 9 existing holdings. Its largest new stake was Protagonist Therapeutics: 121,400 shares worth $5.87M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 98% a quarter earlier, followed by Materials and Technology.

On the sell side, the largest reduction was BeOne Medicines Ltd, an estimated $999K trimmed.

  • Nan Fung Group Holdings's largest Q1 2025 buy was Protagonist Therapeutics: 121,400 shares worth $5.87M.
  • Nan Fung Group Holdings added most to Xenon Pharmaceuticals in Q1 2025, an estimated $1.97M increase.
  • Nan Fung Group Holdings's biggest Q1 2025 reduction was BeOne Medicines Ltd, cutting an estimated $999K.
  • Nan Fung Group Holdings fully exited Rubrik in Q1 2025, selling an estimated $1.59M.
  • Nan Fung Group Holdings's ten largest holdings make up 64% of its $123M portfolio in Q1 2025.
  • Nan Fung Group Holdings opened 1 new position and closed 1 in Q1 2025.
  • Nan Fung Group Holdings's portfolio value rose 4.9% quarter-over-quarter to $123M.

Based on Nan Fung Group Holdings's 13F filing for Q1 2025, filed 14 May 2025.